Home Page Twitter Facebook Linked-In YouTube Home Page Join List-Serve Privacy Policy ADAP Advocacy Association

About ADAPs About Us Contact Us Events Publications Media Clips Press Room Support

About giving more than just a handfull of hope...aaa+

HEAR. HELP. HEAL. HOPE.

The ADAP Advocacy Association (aaa+®) mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. aaa+® works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to raise awareness, offer patient educational program, and foster greater community collaboration.

aaa+® is the only national grassroots organization focused exclusively on ADAPs and ensuring that there are adequate resources nationwide to eliminate or prevent waiting lists for services. Our purpose is to better engage people living with HIV/AIDS by providing a platform whereby they can offer their personal experiences, challenges, knowledge, insight and solutions to solving this perpetual problem.

—> Join List-Serve

Breaking News

On World AIDS Day, ADAP Advocacy Association Asks President-Elect Donald J. Trump: “Don’t Turn Your Back on AIDS”

New Administration Urged to Continue the Fight Against HIV/AIDS

WASHINGTON, D.C. - (Dectember 1, 2016) - The ADAP Advocacy Association - also known as aaa+®, today on World AIDS Day urged President-Elect Donald J. Trump to continue the fight against HIV/AIDS. “Don’t Turn Your Back on AIDS” – an awareness campaign using art launched several years ago in Oakland, California by the Flowers Heritage Foundation – embodies the message being sent to the incoming 45th President of the United States.  
[PDF | DOC]

ADAP Blog

Why HIV Medical Treatment Guidelines Matter
By: Brandon M. Macsata, CEO, ADAP Advocacy Association

As with all chronic diseases and conditions the approved medical treatment guidelines serve as an important marker, not only for patients and the medical professionals who treat them, but also the payors. This is certainly no different with HIV/AIDS. That is why the ADAP Advocacy Association is calling on the Health Resources and Services Administration ("HRSA") at the U.S. Department of Health & Human Services to update its treatment guidelines for HIV-associated lipodystrophy. HRSA’s current guidelines need to correct a statement regarding growth hormone-releasing factor, because it does not accurately reflect the available treatment to patients suffering from lipodystrophy disease.

» CLICK HERE to read more.

ADAP Update

ADAPs with Waiting Lists
(0 individuals as of October 14, 2014)
Source: The ADAP Watch, National Alliance of State & Territorial AIDS Directors (NASTAD).

  • ADAP waiting lists were officially eliminated as of November 2014.

» CLICK HERE to read more.

Support Our Scholarship Fund

ADAP Directory

Home · Join List-Serve · About ADAPs · About Us · Blog · Events · Publications
Media Clips · Press Room · Support · Privacy · Contact Us